Intelligent Bio Solutions Inc. Files 8-K
Ticker: INBS · Form: 8-K · Filed: Sep 25, 2025 · CIK: 1725430
Sentiment: neutral
Topics: 8-K, financial-statements, exhibits
TL;DR
IBSI filed an 8-K on 9/25 for events on 9/20, mostly financial docs.
AI Summary
Intelligent Bio Solutions Inc. filed an 8-K on September 25, 2025, reporting events as of September 20, 2025. The filing primarily concerns financial statements and exhibits, with no specific material events detailed in the provided text.
Why It Matters
This filing indicates a routine update or submission of financial information and exhibits by Intelligent Bio Solutions Inc. to the SEC.
Risk Assessment
Risk Level: low — The filing appears to be a standard procedural submission of financial statements and exhibits, not indicating any immediate material changes or risks.
Key Numbers
- 001-39825 — SEC File Number (Identifier for Intelligent Bio Solutions Inc.)
- 821512711 — EIN (Employer Identification Number for Intelligent Bio Solutions Inc.)
Key Players & Entities
- INTELLIGENT BIO SOLUTIONS INC. (company) — Registrant
- 0001725430 (company) — Central Index Key
- GBS Inc. (company) — Former Company Name
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (company) — Former Company Name
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of September 20, 2025.
When was this 8-K report filed with the SEC?
This 8-K report was filed with the SEC on September 25, 2025.
What is the exact name of the registrant?
The exact name of the registrant is INTELLIGENT BIO SOLUTIONS INC.
What were the previous names of Intelligent Bio Solutions Inc.?
The previous names of Intelligent Bio Solutions Inc. were GBS Inc. and Glucose Biosensor Systems (Greater China) Holdings, Inc.
What is the principal executive office address for Intelligent Bio Solutions Inc.?
The principal executive office address is 135 West 41st Street, 5th Floor, New York, NY 10036.
Filing Stats: 575 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2025-09-25 17:00:32
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INBS The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 37KB
- ex4-1.htm (EX-4.1) — 133KB
- 0001493152-25-014961.txt ( ) — 363KB
- inbs-20250920.xsd (EX-101.SCH) — 3KB
- inbs-20250920_lab.xml (EX-101.LAB) — 33KB
- inbs-20250920_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 25, 2025 INTELLIGENT BIO SOLUTIONS INC. By: /s/ Spiro Sakiris Name: Spiro Sakiris Title: Chief Financial Officer